Filling the drug discovery gap: is high-content screening the missing link?

08:00 EDT 19th July 2018 | BioPortfolio

Summary of "Filling the drug discovery gap: is high-content screening the missing link?"

In recent years, questions about the sustainability of the current drug discovery process have triggered a revival of interest in phenotypic drug discovery approaches. This trend has clearly been amplified by the emergence of multiple cell-based assay technologies enabling a higher degree of translatability between in vitro conditions and physio-pathological situations, including induced pluripotent stem cells, three-dimensional models, co-culture and organ-on-a-chip systems, complemented by advances in gene editing technologies. Progress in High-Content Screening technology has also contributed to the recent excitement for phenotypic drug discovery approaches, bringing image-capture and processing, and data-analysis, to a level of content and throughput fully compatible with large scale drug discovery efforts. Nevertheless, implementation of HCS in discovery projects must be carefully considered, to ensure optimal performance and the generation of relevant data to enable the discovery of first-in-class medicines.


Journal Details

This article was published in the following journal.

Name: Current opinion in pharmacology
ISSN: 1471-4973
Pages: 40-45


DeepDyve research library

PubMed Articles [29537 Associated PubMed Articles listed on BioPortfolio]

Society of Biomolecular Imaging and Informatics High-Content Screening/High-Content Analysis Preclinical Translational Imaging Colloquium: How Emerging Technologies in Disease Models, High-Content Imaging, and Data Analytics Are Changing Our Approach to Drug Discovery.

High-Content and High-Throughput In Vivo Drug Screening Platforms Using Microfluidics.

The drug-discovery process is expensive and lengthy, and has been causing a rapid increase in the global health care cost. Despite extensive efforts, many human diseases still lack a cure. To improve ...

Inkjet dispensing technologies: recent advances for novel drug discovery.

Inkjet-dispensing printing is a promising additive manufacturing method for pharmaceutical applications such as drug discovery. The unique advantages of this technology, including low cost, programmab...

Evolution of commercially available compounds for HTS.

Over recent years, an industry of compound suppliers has grown to provide drug discovery with screening compounds: it is estimated that there are over 16 million compounds available from these sources...

Microfluidics contribution to pharmaceutical sciences: From drug discovery to post marketing product management.

Drug discovery and development is a long-lasting process in which many challenges have to be addressed at every stage, from the discovery of the target biomolecule to the commercialization of the disc...

Clinical Trials [9984 Associated Clinical Trials listed on BioPortfolio]

Development of a Screening Strategy for Community-Based Adverse Drug Related Events in the Emergency Department

Adverse Drug Related Events (ADREs) are a leading cause of Emergency Department (ED) visits in Canada. However emergency physicians recognize only half of all ADREs in patients presenting ...

Comparison Between Different Filling Pressures in Operative Outpatient Hysteroscopy

The study aims to compare different filling pressures in operative outpatient hysteroscopy. Women will be divided into 3 groups. The hysteroscope will be introduced in the uterine cavity. ...

Clinical Evaluation of Basic Filling Material in Class I and II Posterior Restorations

Evaluation of a new basic filling restorative material. In contemporary dentistry, clinicians have essentially three types of material choices for direct restorations: amalgam, resin comp...

Increasing Primary Care Physician Colorectal Cancer Screening Rates

The purpose of the study is to determine if a Web-based intervention increases physician rates of colorectal cancer recommendation rates in a group of physicians participating in the Ameri...

Cancer Stem Cell High-Throughput Drug Screening Study

A study to determine the safety of CSC/ HTS-based combination drug therapy in subjects who have GBM that has recurred or progressed following prior radiation therapy and TMZ.

Medical and Biotech [MESH] Definitions

The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates (INFANT, NEWBORN) from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic.

An order of GRAM-NEGATIVE OXYGENIC PHOTOSYNTHETIC BACTERIA containing CHLOROPHYLL, a and b, but lacking PHYCOBILISOMES (light-harvesting antennae). There are three genera: PROCHLORON; PROCHLOROCOCCUS; and PROCHLOROTHRIX. This order was thought to be the missing link between CYANOBACTERIA and plant CHLOROPLASTS, hence the name.

The process of finding chemicals for potential therapeutic use.

A diet that consists mainly of foods with a high content of protein and limited amounts of CARBOHYDRATES.

Glycoproteins which have a very high polysaccharide content.

Quick Search


DeepDyve research library

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...

Searches Linking to this Article